Aptevo: Developing Meaningful Therapeutics that Produce Promising Outcomes in the Fight Against Cancer

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific and trispecific immunotherapies for the treatment of cancer. Aptevo is seeking to improve treatment outcomes and transform the lives of cancer patients.